Abstract
Biomarkers can be used to aid the diagnosis of a disease (particularly early detection of occult tumours), to aid in the staging of disease, to predict outcome of disease, to act as a surrogate for clinical progression and to monitor responses to treatment. It is therefore important when referring to biomarkers to state exactly which of these indications is being sought. There is a real clinical need for biomarkers in all these stages, especially where patient stratification prior to treatment can considerably improve the outcome of clinical trials. Cancer, being a heterogeneous disease, is unlikely to respond to any one specific treatment and biomarkers that could tell us if the patient and their cancer was resistant to certain drugs would be very useful and, indeed, these are being sought. In an analogous way these are even more necessary with regards to vaccines, which would benefit greatly from patient stratification and early prediction of disease response [1].
Keywords: Biomarkers, cancer vaccines, cytokine profiles
Current Cancer Therapy Reviews
Title: Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines
Volume: 4 Issue: 2
Author(s): Angus G. Dalgleish
Affiliation:
Keywords: Biomarkers, cancer vaccines, cytokine profiles
Abstract: Biomarkers can be used to aid the diagnosis of a disease (particularly early detection of occult tumours), to aid in the staging of disease, to predict outcome of disease, to act as a surrogate for clinical progression and to monitor responses to treatment. It is therefore important when referring to biomarkers to state exactly which of these indications is being sought. There is a real clinical need for biomarkers in all these stages, especially where patient stratification prior to treatment can considerably improve the outcome of clinical trials. Cancer, being a heterogeneous disease, is unlikely to respond to any one specific treatment and biomarkers that could tell us if the patient and their cancer was resistant to certain drugs would be very useful and, indeed, these are being sought. In an analogous way these are even more necessary with regards to vaccines, which would benefit greatly from patient stratification and early prediction of disease response [1].
Export Options
About this article
Cite this article as:
Dalgleish G. Angus, Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310098
DOI https://dx.doi.org/10.2174/157339408784310098 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Management of Early Stage Cervical Cancer
Reviews on Recent Clinical Trials Role of Alterations in the Apoptotic Machinery in Sensitivity of Cancer Cells to Treatment
Current Pharmaceutical Design Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Current Medicinal Chemistry An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors
Current Cancer Drug Targets <i>Taraxacum officinale</i> Extracts Exhibit Safe and Selective Anticancer Activity
The Natural Products Journal Heparanase as a Target in Cancer Therapy
Current Cancer Drug Targets Chlorophylls and their Derivatives Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies
Current Cancer Therapy Reviews Design and Synthesis of 3,4-diarylpyrrole Analogues as Potent Topoisomerase Inhibitors
Medicinal Chemistry New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design The Initiation Mechanisms of Gene Expression in Ascitic Hepatoma Cells Under the Action of Dehydroepiandrosterone in a Complex with Apolipoprotein A-I
Current Chemical Biology Proteomic and Metallomic Strategies for Understanding the Mode of Action of Anticancer Metallodrugs
Anti-Cancer Agents in Medicinal Chemistry Formulation Strategies and Particle Engineering Technologies for Pulmonary Delivery of Biopharmaceuticals
Current Pharmaceutical Design Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and <i>in vitro</i> Studies
Current Cancer Drug Targets Oncolytic Viruses Driven by Tumor-Specific Promoters
Current Cancer Drug Targets A Review of Fertility Preservation with Radical Vaginal Trachelectomy and Laparoscopic Pelvic Lymphadenectomy in the Treatment of Early Cervical Cancer
Current Women`s Health Reviews Effects of Brain IKKβ Gene Silencing by Small Interfering RNA on P-Glycoprotein Expression and Brain Damage in the Rat Kainic Acid-Induced Seizure Model
CNS & Neurological Disorders - Drug Targets Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances
Current Cancer Therapy Reviews In Silico Screening of Novel Inhibitors for HPV: A Rational Structure Based Approach (Docking Versus Pharmacophore Model Generation)
Letters in Drug Design & Discovery E6 and E7 Oncoproteins: Potential Targets of Cervical Cancer
Current Medicinal Chemistry